Home News

2017 first half results presentation

Operating revenues, growth data, profitability and the behavior of our products.

Wed, 26/07/2017 - 12:28 0 min
Download related document
No votes yet
 
Related
ROVI Announces Positive Topline Results from Phase 3 study of Doria® in...
Laboratorios Farmacéuticos Rovi, S.A. (www.rovi.es) today announced topline results from the pivotal study PRISMA-3, a multicenter,...
4 min
19/03/2019
2018 full year results presentation
0 min
26/02/2019
ROVI reports operating revenue growth of 10%, underpinned by the behaviour of...
The operating revenue of Laboratorios Farmacéuticos ROVI increased by 10% to 303.2 million euros in 2018, driven mainly by the strength of...
5 min
26/02/2019